Home＜ News & Events

News & Events

News Events Media Attention Partner News

 

2021.12
10

TOT BIOPHARM: Make the public benefited from the innovation
2021.11
24

How TOT BIOPHARM deploys innovative drug development and CDMO based on patients needs? ｜ Jianghu
2021.07
08

Enter the CDMO field, TOT BIOPHARM explores the “Optimal Solution” for innovative drug development
2021.05
31

TOT BIOPHARM: low-risk development model in high-risk areas
2021.03
08

Prof. Yongmei Yin: TAA013, a novel ADC drug stands out as a “Chinese Solution” for anti-HER2 targeted therapy
2021.03
03

TAA013, a new treatment option for HER2-positive against breast cancer
Baidu
map